🇦🇹 Austria Country × Condition
diffuse large b cell lymphoma Clinical Trials in Austria
Active clinical trials for diffuse large b cell lymphoma with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇦🇹 Austria
Active Trials in Austria (2)
NCT06830759
Recruiting
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
Enrollment
700 pts
Country
🇦🇹 Austria
AbbVie
View Trial → NCT02227251 Phase 2
Recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Enrollment
244 pts
Country
🇦🇹 Austria
Karyopharm Therapeutics Inc
View Trial → Frequently Asked Questions
How many diffuse large b cell lymphoma clinical trials are active in Austria?
There are currently 2 active clinical trials for diffuse large b cell lymphoma with sites in Austria, of which 2 are actively recruiting patients.
How can I join a diffuse large b cell lymphoma clinical trial in Austria?
To join a diffuse large b cell lymphoma clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are diffuse large b cell lymphoma trials in Austria?
Active diffuse large b cell lymphoma trials in Austria span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.